Saarland-founded AkknaTek is developing an imaging aid for cataract surgery to improve the precision of intraocular lenses implanted during the procedure.
AkknaTek, a Germany-based ophthalmological technology developer based at University of Saarland, secured an undisclosed amount of funding today from EU and state-backed regional development vehicle Investment and Structural Bank Rheinland-Pfalz.
The company is working on ophthalmological tools led by an imaging aid for cataract surgery that would improve visual outcomes for patients by precisely identifying the optimum spot on the eye to insert the intraocular lens implant during the procedure.
An estimated 800,000 cataract operations per year in Germany result in suboptimal results for the patient. The capital will go towards building AkknaTek’s first prototype, with a view to attaining regulatory approvals and proving up its target market.
AkknaTek is situated in University of Saarland’s startup incubator in Saarbrücken and has previously received prize funding through the Founder’s Contest Digital Innovations contest. It also received logistical support from DHC Business Solutions Ventures, an early-stage investment subsidiary of compliance management software publisher DHC Business Solutions.
